Brazil to Import two Million AstraZeneca Vaccine Doses, not yet Approved for Use

RIO DE JANEIRO, BRAZIL -Brazil’s health regulator Anvisa said late on Saturday, January 2nd, it had approved the import of 2 million doses of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, although the jab is not yet approved for use in the country.

Anvisa said it approved the importation request from federal government-affiliated biomedical center Fiocruz on Thursday.

Importing the doses prior to approval will enable vaccination to begin as soon as Anvisa okays its use, the regulator said. Brazil has yet to approve any vaccine.

Fiocruz will apply for emergency use of the vaccine by Wednesday, its president, Nísia Trindade, said last week.

Brazil has recorded the second-deadliest outbreak of COVID-19 after only the United States. South America’s largest country has the third highest tally of coronavirus cases, with the health ministry registering more than 7.7 million, after the United States and India.

Source: Reuters

Related coverage: Muslims Keep Arabic Language Alive in Brazil · Florida Scientist Says Parts of Amazon Rainforest will Collapse, Become Arid by 2064 · Brazil Wildfires Surge 12.7% to 222,798 in 2020 · Court Orders Closing of Non-essential Activities for 15 Days in Brazil´s Amazonas State

More: Brazil news in English, every day from The Rio Times.

Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error